Aelis Farma SA

Research Aelis Farma SA (AELIS) on Bullrun: market cap EUR 13.32M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAELIS
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 13.32M
• Financial periodFY2025
• Revenue growth-100.0%
• Net income-EUR 6.43M
• Free cash flow-EUR 5.36M

Valuation Snapshot

latest market cap is EUR 13.32M.

About Aelis Farma SA

Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use;

Frequently asked questions

What is Aelis Farma SA's market cap?

Aelis Farma SA's market capitalization is EUR 13.32M.

What does Aelis Farma SA do?

Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.